Pathophysiology of Autoimmune Diseases
A special issue of Pathophysiology (ISSN 1873-149X).
Deadline for manuscript submissions: closed (31 March 2022) | Viewed by 21902
Special Issue Editors
Interests: autoimmunity; autoimmune diseases; aetiology; pathogenesis; models; experimental therapy; geoepidemiology; adjuvants; ASIA-syndrome; dysautonomia; infertility; adverse effects of checkpoint inhibitor therapy; functional antibodies; physiologic autoimmunity; autoimmunity and microbiota; autoimmunity and cancer; autoimmunity and vaccines; COVID-19 and autoimmunity
2. Laboratory of the Mosaics of Autoimmunity, Saint Petersburg State University, 199034 Saint-Petersburg, Russia
Interests: clinical immunology; autoimmune diseases; rheumatology diseases; lupus
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The development of autoimmune diseases is multifactorial and subordinated to laws of the additive polygenetic inheritance with the threshold effect from the side of a whole series of natural and sociocultural anthropogenic epigenetic factors, sometimes even including iatrogenic ones. Since the autoimmune diseases of different organs and systems have much in common considering their pathophysiology, clinical manifestations, as well as their prevention and treatment approaches, a new interdisciplinary branch of medicine—autoimmunology—has formed recently in front of our eyes. About 90 autoimmune diseases have been described, which implicate all organs and systems and belong to the sphere of all medical specializations. Autoimmune diseases’ morbidity and mortality steadily grow in all developed countries. There is strong evidence for existence of autoimmune/autoinflammatory links in the pathogenesis of severe COVID-19 cases of current global pandemic. In spite of the successes in the study of the etiology, pathogenesis, and models of many autoimmune illnesses, the nature of the general disturbances, which underlie various particular forms of autoimmune disorders, remains the urgent object of scientific studies and discussions. At the same time, practical healthcare worldwide experiences the utmost need for target prophylaxis and effective modalities of autoimmune disorder treatment, and minimization of their adverse effects. The evolution of nature and development of civilization set many new challenges for biomedical science and for healthcare systems, including new risk factors of autoimmune diseases; hence, there is a great possibility that the 21st century will turn into an aeon of autoimmunity.
This trend may in future change the whole philosophy of clinical medicine. Currently, it is believed that autoimmune diseases are induced through a combination of genetic and environmental factors. The genotype distinguishes individuals who may possess inherited characteristics, making their immune system hyperactive (e.g., HLA DRb1). The environmental factors include, first of all, those compounds that have an adjuvant effect (from the Latin word adjuvare—“to help or aid”). This means that such a factor may enhance immune responses modifying the immunoregulating interactions. In the presence of primary individual hereditary predisposition, pathological autoimmunity can manifest differently under the influence of various exogenous adjuvants or, vice versa—immunosuppressive factors—interplaying at different life periods of a concrete person, while autoimmune disorders in the human body seem to flow from one nosological entity to another, keeping a similar background which is a principle known as the “kaleidoscope of autoimmunity”. The Special Issue of Pathophysiology dedicated to autoimmunity problems aims to attract both researchers and clinicians of various specialties and contributions by leading scholars of this scientific area.
Dr. Leonid Churilov
Prof. Dr. Yehuda Shoenfeld
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathophysiology is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- autoimmunity
- autoimmune diseases
- etiology
- pathogenesis
- models
- experimental therapy
- geoepidemiology
- adjuvants
- ASIA syndrome
- dysautonomia
- infertility
- adverse effects of checkpoint inhibitor therapy
- functional antibodies
- physiologic autoimmunity
- autoimmunity and microbiota
- autoimmunity and cancer
- autoimmunity and vaccines
- COVID-19 and autoimmunity cardiovascular diseases
- arteries
- vasodilation
- blood pressure
- prostacyclin
- nitric oxide
- adenosine
- hyperpolarization
- polyphenolic substances
- nanoparticles
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.